Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Oral Mucositis: Side Effect Of Anticancer Therapy Highlighted During Breast Cancer Awareness Month
http://www.medicalnewstoday.com/articles/125910.php
As millions of Americans participate in educational initiatives as part of National Breast Cancer Awareness Month, they should keep in mind an important yet under-recognized consequence of breast cancer therapy: oral mucositis, one of the most common and debilitating side effects of cancer treatment.
Black Women's Breast Cancer Disparities Related To Inadequate Health System, Opinion Piece Says
http://www.medicalnewstoday.com/articles/125822.php
Part of black women's "increased vulnerability to breast cancer is a result of differential access to health care and health services," Julianne Malveaux, president of <a href="http://www.bennett.
Kidney And Adrenal Tumors II - Coverage From The 60th Annual Congress Of The German Urological Association
http://www.medicalnewstoday.com/articles/125780.php
STUTTGART, GERMANY (UroToday.com) - The impact of microscopic versus macroscopic vascular invasion on metastasis-free survival was analyzed in 2,394 re-evaluated kidney cancer specimens from Graz (Austria).
National Breast Cancer Awareness Month Shines Spotlight On Oral Mucositis As A Common Side Effect Of Anticancer Therapy
http://www.medicalnewstoday.com/articles/125763.php
As millions of Americans participate in educational initiatives as part of National Breast Cancer Awareness Month, they should keep in mind an important yet under-recognized consequence of breast cancer therapy: oral mucositis, one of the most common and debilitating side effects of cancer treatment.
----------------------------------------------
** CANCER / ONCOLOGY News **
College Team Create Anticancer 'BioBeer' For Entry In Synthetic Biology's IGEM Contest:
http://www.medicalnewstoday.com/articles/125887.php
College students often spend their free time thinking about beer, but a group of Rice University students are taking it to the next level. They're using genetic engineering to create beer that contains resveratrol, a chemical in wine that's been shown to reduce cancer and heart disease in lab animals.
MIT: Computer Model Reveals Cells' Inner Workings - New Approach Could Help Tailor Chemotherapy Treatments
http://www.medicalnewstoday.com/articles/125881.php
After spending years developing a computational model to help illuminate cell signaling pathways, a team of MIT researchers decided to see what would happen if they "broke" the model.The results, reported in the Oct.
Histopathologic Analysis Of Peritumoral Pseudocapsule And Surgical Margin Status After Tumor Enucleation For Renal Cell Carcinoma
http://www.medicalnewstoday.com/articles/125836.php
UroToday.com - The wide acceptance and approval of a surgical technique aiming to cure patients with RCC depends on the technical feasibility and excellent results reported in retrospective series [1-4], along with prospective confirmation on pathological examination of its oncological safety.
Surgeons Find Unsuspected Thyroid Cancer In Elderly Patients Through Routine Imaging Studies For Other Conditions
http://www.medicalnewstoday.com/articles/125832.php
Routine imaging studies of older patients are finding thyroid nodules that may be malignant before they cause signs or symptoms of the disease according to a study by surgeons at Rush University Medical Center presented at the 2008 Clinical Congress of the American College of Surgeons on October 15.
Extrarenal Multiorgan Metastases Of Collecting Duct Carcinoma Of Kidney: A Case Series
http://www.medicalnewstoday.com/articles/125820.php
UroToday.com - Collecting duct carcinoma (CDC) is a rare type of kidney tumor accounting for 0.4% to 1.8% of all renal cell carcinomas. It is derived from the renal medulla, possibly from the distal collecting duct of Bellini.
Transitional Cell Carcinoma: Experimental - Coverage From The 60th Annual Congress Of The German Urological Association
http://www.medicalnewstoday.com/articles/125810.php
STUTTGART, GERMANY (UroToday.com) - Apoptotic DNA fragments in serum of patients with muscle-invasive bladder cancer are of prognostic relevance. The authors compared 45 patients with muscle-invasive bladder cancer and 45 patients with BPH.
Transitional Cell Carcinoma: Diagnosis - Coverage From The 60th Annual Congress Of The German Urological Association
http://www.medicalnewstoday.com/articles/125803.php
STUTTGART, GERMANY (UroToday.com) - Interobserver variability of urine cytology was investigated by members of the working group "Urine Cytology" of the DGU. Four experienced cytologists analyzed 45 benign and 105 malignant urine specimens, respectively.
Transitional Cell Carcinoma: Diagnosis II - Coverage From The 60th Annual Congress Of The German Urological Association
http://www.medicalnewstoday.com/articles/125790.php
STUTTGART, GERMANY (UroToday.com) - The prognostic value of tumor architecture (papillary versus solid) in 1,363 patients with transitional cell carcinoma of the upper urinary tract was investigated by 12 institutions.
Kidney And Adrenal Tumors - Coverage From The 60th Annual Congress Of The German Urological Association
http://www.medicalnewstoday.com/articles/125781.php
STUTTGART, GERMANY (UroToday.com) - The current role of immunotherapy of metastatic kidney cancer in the era of targeted therapy was investigated with a survey among German urologists and oncologists - in private practice and in hospital.
Genital And Testis Tumors - Coverage From The 60th Annual Congress Of The German Urological Association
http://www.medicalnewstoday.com/articles/125779.php
STUTTGART, GERMANY (UroToday.com) - Height is associated with a higher risk for the development of testicular cancer as shown in a case-control study of 6,415 patients with testicular cancer from 103 German institutions.
Immunotherapy And Quick Action Key To Fighting Anti-NMDA-receptor Encephalitis Tumor
http://www.medicalnewstoday.com/articles/125769.php
An article published early online and in the December edition of <span style="font-style: italic;">The Lancet Neurology</span>describes theclinical features of 100 patients who were diagnosed with the newlydiscovered anti-NMDA-receptor encephalitis (ANRE).
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Chronic Myeloid Leukemia - Data From EUTOS For CML Demonstrate Need For Improved Management And Dose Optimization Across Europe
http://www.medicalnewstoday.com/articles/125886.php
One-year data from the European Treatment and Outcome Study (EUTOS) for Chronic Myeloid Leukemia (CML), presented here today, provide a clear rationale for the initiative's program of close disease management and therapeutic monitoring.
Landmark Study Demonstrates Potential Of Radioimmunotherapy For Treatment Of Indolent B-Cell Non-Hodgkin's Lymphoma
http://www.medicalnewstoday.com/articles/125759.php
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that the Journal of Clinical Oncology has published the results of the First-line Indolent Trial (FIT) demonstrating that use of Zevalin(R)([90Y]-ibritumomab tiuxetan) in consolidation therapy after remission induction in previously untreated patients with follicular non-Hodgkin's lymphoma provided important patient benefits including a significant improvement in progression free survival.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Prognostic Value Of Her-2/Neu & DNA Index For Progression, Metastasis & Prostate Cancer-Specific Death In Men With Follow-Up After Prostatectomy
http://www.medicalnewstoday.com/articles/125838.php
BERKELEY, CA (UroToday.com) - Why were these results achievable? This study was planned and initiated in 1992 while Dr. Veltri was serving as Vice President & GM for Research and Development of the UroCor Inc.
Prostate Cancer: Biomarkers - Coverage From The 60th Annual Congress Of The German Urological Association
http://www.medicalnewstoday.com/articles/125784.php
STUTTGART, GERMANY (UroToday.com) - The value of PCA3 in urine was investigated in a prospective European trial on 463 patients who had previously undergone one or two negative prostate biopsies and who were scheduled for a re-biopsy of their prostate.
Optimized Radiation For Prostate Cancer Therapy
http://www.medicalnewstoday.com/articles/125771.php
The determination of the precise anatomical location of a tumor is the prerequisite for setting optimal parameters for radiation treatment of prostate cancer. This approach guarantees that the ionizing radiation only destroys tumorous cells and does not affect other organs in the vicinity of the prostate.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment